Furthermore, the inhibition or downregulation of MDK using RNA interference (RNAi) or siRNA has been shown to enhance the effectiveness of chemotherapeutic agents by restoring drug sensitivity in resistant cancer cells [148, 162]. The gene discussed is MDK; the disease is cancer.